Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Ascletis Pharmaceuticals Co. Ltd.

Headquarters: Shaoxing, China
Website: N/A
Year Founded: 2011
Status: Out of Business

BioCentury | Nov 30, 2020
Management Tracks

New CMO and Takeda alum Palmer adds to Ascletis’ push into NASH

Ascletis is looking to Takeda veteran Melissa Palmer to move its pipeline of in-licensed and homegrown NASH programs forward. Ascletis Pharma Inc. (HKEX:1672) announced Monday that Palmer, the
BioCentury | Feb 8, 2020
Product Development

Coronavirus biology: where products in clinical testing intervene

An overview of how therapies in clinical trials for coronavirus interfere with viral biology
BioCentury | Jun 15, 2018
Clinical News

Chinese approval for Ascletis' HCV drug

BioCentury | Jun 13, 2018
Company News

Chinese approval for Ascletis' HCV drug

BioCentury | May 25, 2018
Finance

HKEX’s on-demand experts

How HKEX plans to leverage its biotech advisory panel
BioCentury | Dec 2, 2017
Strategy

Opening the gates in China

HCV competition in China shows how regulatory changes have leveled the field
BioCentury | Jan 6, 2017
Finance

Preparing to strike

How Ascletis will use its $100M B round to expand beyond HCV
Items per page:
1 - 10 of 41
Help Center
Username
Request a Demo
Request Training
Ask a Question